You searched for: congenital (Danska - Engelska)

congenital anomalies 32; :381-391.
congenital anomalies 32, p. 381-391.

treatment of emphysema secondary to congenital alpha- 1
•

treatment of emphysema secondary to congenital alpha1 - antitrypsin deficieny
treatment of emphysema secondary to congenital alpha 1- antitrypsin deficieny

treatment of emphysema secondary to congenital alpha- 1 - antitrypsin deficiency
treatment of emphysema secondary to congenital alpha-1- antitrypsin deficiency

indicated in purpura fulminans and coumarin induced skin necrosis in patients with severe congenital protein
necrosis in patients with severe

b01ax indicated in purpura fulminans and coumarin induced skin necrosis in patients with severe congenital protein c deficiency r07ax treatment of newborns with hypoxic respiratory failure
· fujisawa gmbh· cell therapeutics (uk) ltdtherapeutic area · atc code · indication

persisterende, pulmonal hypertension hos nyfødte (pphn) optræder som en primær udviklingsdefekt eller som en tilstand sekundær til andre sygdomme så som mekonium-aspirationssyndrom (mas), pneumoni, sepsis, hyalinmembran-sygdom, medfødt diafragmahernie (congenital diaphragmatic hernia (cdh)) og pulmonal hypoplasi.
persistent pulmonary hypertension of the newborn (pphn) occurs as a primary developmental defect or as a condition secondary to other diseases such as meconium aspiration syndrome (mas), pneumonia, sepsis, hyaline membrane disease, congenital diaphragmatic hernia (cdh), and pulmonary hypoplasia.